Skip to content

PTSD: all studies

Page 162 of 210: studies 1,611 to 1,620 of 2,096, newest first. Back to the PTSD overview

Research

Pandemic dreams: A thematic analysis of university students’ dreams during the COVID-19 outbreak.

Dreaming August 18, 2022 Mahsum Avci

The aim of this study is to investigate how the COVID-19 pandemic affects the dream content of university students. This research, which is based on a qualitative design, is based on a phenomenological approach. The group of the study was determined by purposive sampling, and 221 dreams that 115 university students had recently and that were not repetitive (it was emphasized that dreams were...

Changing attitudes to psychedelic drug assisted therapy: The induction of empathy to enhance community support for innovative interventions in mental health

Journal of Psychedelic Studies August 18, 2022 Corey Botansky, John Innes 2 citations

Abstract Empirical research supports the use of psychoactive drugs to augment psychotherapy for the treatment of mental illness. The use of such drugs, however, is still resisted by many in the medical community and this transfers to resistance in the wider community. The stigma of controversy surrounding the drugs, further enhanced by the stigma of mental illness, hinders community acceptance....

DOI: 10.1556/2054.2022.00203 (opens in new tab) Full text (opens in new tab) Empathy Mental illness Stigma botany Psychological intervention +3

A-118 Psychedelic Interventions for Neuropsychological Conditions

Archives of Clinical Neuropsychology August 17, 2022 Brian Peacock 3 citations

Abstract Objective: Psychedelic-assisted therapies are emerging as safe and effective treatments for some psychological conditions including depression, anxiety, posttraumatic stress disorder, and substance use disorders. As ketamine therapy is already available in general medicine and 3,4 Methylenedioxymethamphetamine (MDMA) and psilocybin are in late-stage clinical trials, neuropsychologists...

Arketamine, a new rapid-acting antidepressant: A historical review and future directions

Neuropharmacology August 14, 2022 Ji-Chun Zhang, Wei Yao, Kenji Hashimoto 88 citations

The N-methyl-d-aspartate receptor (NMDAR) antagonist (R,S)-ketamine causes rapid onset and sustained antidepressant actions in treatment-resistant patients with major depressive disorder (MDD) and other psychiatric disorders, such as bipolar disorder and post-traumatic stress disorder. (R,S)-ketamine is a racemic mixture consisting of (R)-ketamine (or arketamine) and (S)-ketamine (or...

DOI: 10.1016/j.neuropharm.2022.109219 (opens in new tab) Antidepressant Psychotherapist Pharmacology

Psychiatry organization does not endorse psychedelic treatment

Alcoholism & Drug Abuse Weekly August 5, 2022 A. Knopf

Last month the American Psychiatric Association (APA) issued a position statement on psychedelics warning about the short‐ and long‐term risks of these unapproved drugs. Sanctioned by the APA board of trustees, the “Position Statement on the Use of Psychedelic and Empathogenic Agents for Mental Health Conditions” notes that preliminary research involving psychedelics for the treatment of...

Reviews for Literature Support on Sleep and Dream Disorder

Zenodo (CERN European Organization for Nuclear Research) August 3, 2022 Assoc. Prof. Kürşat Şahin Yildirimer, Hacı Osman Aktaşlioğlu preprint

There are many studies that discuss the lives of people with frequent dreams in which a clinically violent and traumatic experience plays a role. Dream reports and the findings of the psychological evaluation are included in our explanations. In just six weeks, he was able to begin to change the narratives of his dreams and improve several psychological measures. In this example, we argued that...

Has the COVID-19 Pandemic Traumatized Us Collectively? The Impact of the COVID-19 Pandemic on Mental Health and Sleep Factors via Traumatization: A Multinational Survey

Nature and Science of Sleep August 1, 2022 Brigitte Holzinger, Franziska Nierwetberg, Frances Chung et al. 16 citations

Purpose: The COVID-19 pandemic affects mental health and sleep, resulting in frequent nightmares. Therefore, identifying factors associated with nightmare frequency is important, as it can indicate mental health issues. The study aimed to investigate increases in nightmare frequency comparing the pre-pandemic and pandemic period, and identify its risk factors. Further, the mediating role of...

DOI: 10.2147/nss.s368147 (opens in new tab) Nightmare Mental health Pandemic Logistic regression +2

Nitrous oxide for the treatment of psychiatric disorders: A systematic review of the clinical trial landscape.

Acta Psychiatrica Scandinavica August 1, 2022 Helen Liu, Jaimie Kerzner, Ilya Demchenko et al.

To systematically review published research studies and ongoing clinical trials investigating nitrous oxide (N2 O) in psychiatric disorders, providing an up-to-date snapshot of the clinical research landscape. A comprehensive literature search was conducted for studies published until June 2021 using the OVID databases (MEDLINE, Embase, APA PsycInfo) and the clinical trial registries...

DOI: 10.1111/acps.13432 (opens in new tab) Full text (opens in new tab) Depression Clinical trial Nitrous oxide Psychiatric disorders +1

Top Ten Tips Palliative Care Clinicians Should Know About Psychedelic-Assisted Therapy in the Context of Serious Illness.

Journal of Palliative Medicine August 1, 2022 William E Rosa, Zachary Sager, Megan Miller et al. 49 citations

Psychedelic-assisted therapy (PAT) is a burgeoning treatment with growing interest across a variety of settings and disciplines. Empirical evidence supports PAT as a novel therapeutic approach that provides safe and effective treatment for people suffering from a variety of diagnoses, including treatment-resistant depression, substance use disorder, and post-traumatic stress disorder. Within...

Indigenous Philosophies and the "Psychedelic Renaissance"

Anthropology of Consciousness July 30, 2022 Keith Williams, Osiris Sinuhé González Romero, Michelle Braunstein et al. 68 citations

Abstract The Western world is experiencing a resurgence of interest in the therapeutic potential of psychedelics, most of which are derived from plants or fungi with a history of Indigenous ceremonial use. Recent research has revealed that psychedelic compounds have the potential to address treatment‐resistant depression and anxiety, as well as post‐traumatic stress disorder and addictions....